Sean M. Johnston
Geen lopende functies
Profiel
Sean M.
Johnston worked as a Process Manager at Bristol Myers Squibb Co. and as a Senior Vice President-Operations at Genaera Corp.
He then worked as a Vice President-Manufacturing Operations at Paratek Pharmaceuticals, Inc. from 2012 to 2014.
After that, he worked as a Principal at Lonza, Inc. and Siegfried Chemicals, Inc. He also worked as a Vice President-Pharmaceutical Development at Paratek Pharmaceuticals, Inc. Dr. Johnston received his undergraduate, MBA, and doctorate degrees from the National University of Ireland.
Eerdere bekende functies van Sean M. Johnston
| Bedrijven | Functie | Einde |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | Chief Operating Officer | - |
Siegfried Chemicals, Inc.
 Siegfried Chemicals, Inc. Chemicals: Major DiversifiedProcess Industries Part of Mercuries & Associates Holding Ltd., Siegfried Chemicals, Inc. is a chemical manufacturer. | Corporate Officer/Principal | - |
Lonza, Inc.
 Lonza, Inc. Chemicals: SpecialtyProcess Industries Lonza, Inc. provides chemical ingredient products. The company is headquartered in Allendale, NJ. | Corporate Officer/Principal | - |
Genaera Corp.
 Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Chief Operating Officer | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Opleiding van Sean M. Johnston
| National University of Ireland | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| PARATEK PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
Paratek Pharmaceuticals, Inc. /Old/
 Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Paratek Pharmaceuticals, Inc. operates as a pharmaceutical company that focuses on the discovery, development, and commercialization of medicines. The firm’s lead product candidate, omadacycline, is a new tetracycline-derived, broad-spectrum antibiotic being developed for use as a first-line monotherapy for serious community-acquired bacterial infections where antibiotic resistance is of concern for treating physicians. The company was founded by Stuart B. Levy and Walter A. Gilbert on July 3, 1996 and is headquartered in Boston, MA. | Health Technology |
Lonza, Inc.
Lonza, Inc. Chemicals: SpecialtyProcess Industries Lonza, Inc. provides chemical ingredient products. The company is headquartered in Allendale, NJ. | Process Industries |
Siegfried Chemicals, Inc.
Siegfried Chemicals, Inc. Chemicals: Major DiversifiedProcess Industries Part of Mercuries & Associates Holding Ltd., Siegfried Chemicals, Inc. is a chemical manufacturer. | Process Industries |
